Business Description
Sai Life Sciences Ltd
ISIN : INE570L01029
Total Employee Number:
3,401Compare
Compare
Traded in other countries / regions
SAILIFE.India Index Membership
NIFTY 500 IPO Date
2024-12-18Description
Sai Life Sciences Ltd is an innovator-focused, contract research, development, and manufacturing organization. It provides end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (NCE), to pharmaceutical innovator companies and biotechnology firms. It possesses both; discovery/contract research (CRO) and chemistry, manufacturing, and control (CMC)/contract development and manufacturing organization (CDMO) capabilities. The company has only one reportable segment: contract research, development, and manufacturing. Geographically it operates in India as well as Outside India.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.91 | |||||
Equity-to-Asset | 0.69 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | 0.43 | |||||
Interest Coverage | 11.83 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 15.27 | |||||
Beneish M-Score | -2.24 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 21.5 | |||||
3-Year EBITDA Growth Rate | 50.6 | |||||
3-Year EPS without NRI Growth Rate | 188.5 | |||||
3-Year Book Growth Rate | 40.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 17.47 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 18.43 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 35.33 | |||||
9-Day RSI | 45.92 | |||||
14-Day RSI | 51.51 | |||||
3-1 Month Momentum % | 25.46 | |||||
6-1 Month Momentum % | 22.67 | |||||
12-1 Month Momentum % | 49.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.69 | |||||
Quick Ratio | 1.51 | |||||
Cash Ratio | 0.31 | |||||
Days Inventory | 38.04 | |||||
Days Sales Outstanding | 67.72 | |||||
Days Payable | 82.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.6 | |||||
Shareholder Yield % | 1.11 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 42.81 | |||||
Operating Margin % | 21.18 | |||||
Net Margin % | 15.91 | |||||
EBITDA Margin % | 30.66 | |||||
FCF Margin % | -3.82 | |||||
OCF Margin % | 23.22 | |||||
ROE % | 15.21 | |||||
ROA % | 10.35 | |||||
ROIC % | 13.01 | |||||
3-Year ROIIC % | 23.33 | |||||
ROC (Joel Greenblatt) % | 22.82 | |||||
ROCE % | 19.5 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 73.97 | |||||
Forward PE Ratio | 64.44 | |||||
PE Ratio without NRI | 72.72 | |||||
Price-to-Owner-Earnings | 92.45 | |||||
PS Ratio | 11.78 | |||||
PB Ratio | 10.31 | |||||
Price-to-Tangible-Book | 10.33 | |||||
Price-to-Operating-Cash-Flow | 50.41 | |||||
EV-to-EBIT | 50.81 | |||||
EV-to-EBITDA | 38.2 | |||||
EV-to-Revenue | 11.72 | |||||
EV-to-FCF | -318.72 | |||||
Price-to-Graham-Number | 5.78 | |||||
| Price-to-Net-Current-Asset-Value | 95.47 | |||||
Earnings Yield (Greenblatt) % | 1.97 | |||||
FCF Yield % | -0.33 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sai Life Sciences Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 21,924.92 | ||
| EPS (TTM) (₹) | 16.34 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 24.81 | ||
| 14-Day RSI | 51.51 | ||
| 14-Day ATR (₹) | 37.470999 | ||
| 20-Day SMA (₹) | 1218.395 | ||
| 12-1 Month Momentum % | 49.49 | ||
| 52-Week Range (₹) | 776.25 - 1260 | ||
| Shares Outstanding (Mil) | 212.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sai Life Sciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sai Life Sciences Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sai Life Sciences Ltd Frequently Asked Questions
What is Sai Life Sciences Ltd(NSE:SAILIFE)'s stock price today?
The current price of NSE:SAILIFE is ₹1208.60. The 52 week high of NSE:SAILIFE is ₹1260.00 and 52 week low is ₹776.25.
When is next earnings date of Sai Life Sciences Ltd(NSE:SAILIFE)?
The next earnings date of Sai Life Sciences Ltd(NSE:SAILIFE) is .
Does Sai Life Sciences Ltd(NSE:SAILIFE) pay dividends? If so, how much?
Sai Life Sciences Ltd(NSE:SAILIFE) does not pay dividend.
Press Release
Articles on Sai Life Sciences Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers